# NewAmsterdam Pharma Company N.V. (NAMS)

> Healthcare · NL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NAMS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 3.04M | $ -48.44M | $ -30.64M | N/A | $ 665.22M |
| 2025 | $ 23.04M | $ -208.69M | $ -151.57M | $ 202.0K | $ 683.43M |
| 2024 | $ 47.89M | $ -253.94M | $ -167.37M | $ 448.0K | $ 757.50M |
| 2023 | $ 15.23M | $ -191.31M | $ -140.12M | $ 60.0K | $ 288.39M |
| 2022 | $ 124.79M | $ -19.41M | $ 31.58M | $ 126.0K | $ 430.07M |
| 2021 | $ 0 | $ -50.38M | $ -164.5K | $ 186.5K | $ 56.63M |
| 2020 | $ 0 | $ -5.44M | $ -7.62M | $ 0 | $ 127.46M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.10 |
| Current Ratio | 9.76 |

## Other views

- [Metrics](https://sponda.capital/en/NAMS.md)
- [Charts](https://sponda.capital/en/NAMS/charts.md)
- [Compare](https://sponda.capital/en/NAMS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.